Inventor · disambiguated record
Jianmin Xu
Also filed as: XU JIANMIN
3 granted patents·6 pending applications·9 citations·filing 2012–2022
55Inventor score
Files withDRACEN PHARMACEUTICALS INC2EVONIK OPERATIONS GMBH2AKZO NOBEL CHEMICALS INT BV1CHEN ANDREW XIAN1ROLLS ROYCE DEUTSCHLAND1
Top patents by PatentIndex Score
9 records- 0165US9433287B2Flat panel display device and support base thereofSHENZHEN TCL NEW TECH CO LTD·Filed 2013·Granted Sep 6, 2016·9 cites·16 claims
- 0258US2025134874A1Pharmaceutical formulations comprising 3-({[(4r)-7-{methyl[4-(propan-2-yl)phenyl]amino}-3,4-dihydro-2h-1-benzopyran-4-yl]methyl}amino)pyridine-4-carboxylic acidTACHYON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0349US11434193B2Preparation method for esterquats based on oilEVONIK OPERATIONS GMBH·Filed 2018·Granted Sep 6, 2022·0 cites·20 claims
- 0449US2017009379A1Method for Scouring WoolAKZO NOBEL CHEMICALS INT BV·Filed 2014·Application pending·0 cites
- 0546US11541006B2Aqueous formulation for insoluble drugsCHEN ANDREW XIAN·Filed 2020·Granted Jan 3, 2023·0 cites·19 claims
- 0645US2023372294A1Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration and the use thereofDRACEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0744US2021277260A1Surface coating composition with long durabilityEVONIK OPERATIONS GMBH·Filed 2019·Application pending·0 cites
- 0840US2022332676A1Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for intravenous administration and the use thereofDRACEN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0933US2014314578A1Securing segment for the vibration damping of turbine blades and rotor deviceROLLS ROYCE DEUTSCHLAND·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jianmin Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →